Organisation paid for research Program year 2024 Source: CMS Open Payments

Bend Meml CLNC

Neither a doctor nor a teaching hospital

Research payments

$30,701

18 payments

Through program year 2024, Bend Meml CLNC is reported as receiving $30,701 in research payments, across 18 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$2,000	1
2023	Research	$375	4
2021	Research	$1,603	6
2020	Research	$1,425	2
2019	Research	$25,298	5

Breakdown

Who paid Research payments · program years 2019–2024

Janssen Research & Development, LLC $30,701 18 payments

Studies the money was for Research payments · program years 2019–2024

A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone (DRd) versus lenalidomide and Dexamethasone (Rd) in patients with newly diagnosed multiple myeloma who are not eligible for high dose chemotherapy and autologous stem cell transplant $26,723 7 payments
A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in patients with newly diagnosed multiple myeloma who are not eligible for high dose chemotherapy and autologous stem cell transplant $2,900 10 payments
A Multi Center Randomized Double Blind Placebo Controlled Phase III Study of ARN509 in Men With Non Metastatic M0 Castration Resistant Prostate Cancer $1,078 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.